Mast Energy Developments PLC — Share Issue/Capital Change 2025

Jul 25, 2025

National Storage Mechanism | Additional information

RNS Number : 4893S

Mast Energy Developments PLC

25 July 2025

Mast Energy Developments PLC

(Incorporated in England and Wales)

(Registration Number: 12886458)

LEI :213800HFVHGJ9YGO9F71

Share code on the LSE: MAST

ISIN: GB00BNG90H86

('MED' or 'the Company')

Dated: 25 July 2025

MAST Energy Developments PLC

Exercise of Historic Broker Warrants, Issue of Equity & TVR

Mast Energy Developments PLC ("MED" or "the Company"), the UK-based multi-asset owner, developer, and operator in the rapidly growing Flexible Generation Power market , announces that it has received n otices of exercise for a total of 243,750 new ordinary MED shares at the exercise price of £0.08 (the "Broker Warrant Shares"). The broker warrants were historically issued to nominees of Novum Securities Limited on 29 May 2024 , the details of which are contained in the Company's RNS announcement dated 7 May 2024. The price and number of warrants were re-stated as part of the Company's recent share capital consolidation and re-admission of its ordinary share capital, effective 14 July 2025.

Total Voting Rights

Application will be made for the admission of the 243,750 Broker Warrant Shares to trading on the LSE ("Admi s sion") pursuant to the authorities approved by shareholders at the General Meeting held on 8 July 2025. The Shares will rank pari passu with the existing ordinary shares and it is expected that Admission will become effe c tive at 8.00 a.m . on 30 July 2025 .

Following Admission, the Company's issued share capital will consist of 13,248,927 ordinary shares with voting rights. MED  does not hold any ordinary shares in treasury. This figure of 13,248,927 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they require to notify their interest in, or a change to their interest in, the share capital of the Company under the UK Financial Conduct A u thority's Disclosure Guidance and Transparency Rules.

Following Admission, the beneficial holding of Paul Venter, non-executive director and chairman of the Company,  will change from 15.06% to 14.79% interest in the issued share capital of the Company.

Stay up to date with MED's latest news and updates by joining our emailing list and social media channels, as follows:

MED general enquiries - https://www.med.energy/contact

MED email alerts - https://www.med.energy/rnsannoucements-1

MED LinkedIn page - https://uk.linkedin.com/company/mast-energy-developments-plc

MED X (formerly Twitter) handle - @mastplc

ENDS

This announcement contains inside information for the purposes of the UK version of the Market Abuse Regulation (EU No. 596/2014) as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 ('UK MAR'). Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Pieter Krügel	[email protected]	Mast Energy Developments PLC	CEO
Guy Wheatley, CFA	+44 (0)74 9398 9014	Fortified Securities	Corporate Broker
Jon Belliss	+44 (0)20 7399 9425	Novum Securities	Corporate Broker

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCSEDFLLEISEIW